FIELD: medicine.
SUBSTANCE: invention refers to medicine and pharmacy and is intended for emergency provision of organs and tissues with oxygen and glucose to preserve their viability under conditions of hypoxia and ischemia. Lymph substituent agent for interstitial injections includes, wt%: 0.88 % sodium chloride, 0.06-0.1 % glucose and 0.01-0.02 % hydrogen peroxide, the rest- bidistilled water for injections with pH 7.4, with osmotic activity 280 mosmole/l of water.
EFFECT: lymph substituent agent injected in organs and tissues improves quality of interstitial fluid, provides cells with oxygen and glucose and keeps cell viability under conditions of hypoxia and ischemia.
1 cl
| Title | Year | Author | Number |
|---|---|---|---|
| BLEACHING AGENT | 2014 |
|
RU2589682C1 |
| MEANS FOR PHYSICAL ENDURANCE INCREASE | 2016 |
|
RU2634271C1 |
| BRUISE BLEACHER | 2014 |
|
RU2539380C1 |
| ENERGY DRINK | 2016 |
|
RU2639493C1 |
| E. M. SOIKHER'S HYPEROXYGENATED AGENT FOR VENOUS OXYGEN SATURATION | 2013 |
|
RU2538662C1 |
| WARM ALKALINE SOLUTION OF HYDROGEN PEROXIDE FOR INTRAPULMONARY INJECTION | 2023 |
|
RU2807851C1 |
| AGENT FOR INTRADERMAL BRUISE WHITENING | 2015 |
|
RU2573382C1 |
| AGENT FOR INCREASING RESISTANCE TO HYPOXIA | 2015 |
|
RU2604129C2 |
| AEROSOL FOR INVASIVE MECHANICAL VENTILATION IN COVID-19 | 2020 |
|
RU2742505C1 |
| ARTIFICIAL SPUTUM FOR MODELING RESPIRATORY OBSTRUCTION IN COVID-19 | 2021 |
|
RU2748999C1 |
